Cardiovascular disease, renal disease and other chronic diseases. Earlier intervention is needed in chronic renal disease;Enfermedad cardiovascular, enfermedad renal y otras enfermedades crónicas. Es necesaria una intervención más temprana en la enfermedad renal crónica

Atencion Primaria

Volumn 41, Issue 9, 2009, Pages 511-514

  Martín De Francisco, Ángel Luis ^a   Aguilera García, Luis ^b   Fuster Carulla, Valentí ^c  

^a XXV Congreso Nacional de la Sociedad Española de Cirugía Cardiovascular y Endovascular   (Spain)

^b MEDICINA FAMILIAR Y COMUNITARIA   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INTERVENTION STUDY; KIDNEY DISEASE; KIDNEY FAILURE; MEDICAL LITERATURE; MEDICAL RESEARCH; PREVALENCE; REVIEW;

EID: 68949163775     PISSN: 02126567     EISSN: 15781275     Source Type: Journal    
DOI: 10.1016/j.aprim.2008.12.007     Document Type: Article

References (32)

1. A.J. Collins, S. Li, D.T. Gilbertson, J. Liu, S.C. Chen, and C.A. Herzog Chronic kidney disease and cardiovascular disease in the Medicare population Kidney Int 64 Suppl 87 2003 S24 S31
2. A. Levin, O. Djurdev, B. Barrett, E. Burgess, E. Carlisle, and J. Ethier Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter Am J Kidney Dis 38 2001 1398 1407 (Pubitemid 34193134)
3. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification Am J Kidney Dis 38 Suppl 1 2002 S1 S266
4. Egocheaga MI, Lobos JM, Álvarez F, Alcázar R, Orte L, González E, et al. Documento de Consenso sobre la Enfermedad Renal Crónica. 2007, Sociedad Española de Medicina de Familia y Comunitaria y Sociedad Española de Nefrología. Barcelona. Disponible en: http://www.semfyc.es
5. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
6. V. Fuster Cardiovascular disease and the UN Millennium Development Goals: a serious concern Nat Clin Pract Cardiovasc Med 3 2006 401
7. Y. Amsalem, M. Garty, R. Schwartz, A. Sandach, S. Behar, and A. Caspi Prevalence and significance of unrecognized renal insufficiency in patients with heart failure Eur Heart J 29 2008 1029 1036
8. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
9. J.F. Mann, H.C. Gerstein, Q.L. Yi, J. Franke, E.M. Lonn, B.J. Hoogwerf HOPE Investigators Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study Am J Kidney Dis 42 2003 936 942
10. L.M. Ruilope, A. Salvetti, K. Jamerson, L. Hansson, I. Warnold, and H. Wedel Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study J Am Soc Nephrol 12 2001 218 225
11. N.I. Parikh, S.J. Hwang, M.G. Larson, D. Levy, and C.S. Fox Chroic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study) Am J Cardiol 102 2008 47 53
12. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C. Hsu Chronic Kidney Disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
13. Registros de la Sociedad Española de Nefrología. Disponible en: http://www.senefro.org/.
14. Annual Data Report 2007 de United States Renal Data System. Disponible en: http://www.usrds.org/adr.htm.
15. J. Coresh, C.A. Brad, T. Greene, G. Eknoyan, and A. Levey Prevalence of chronic kidney disease and decreased kidney function in the adults US population: Third National Health and Nutrition Examination Survey Am J Kidney Dis 41 2003 1 12
16. J. Coresh, E. Selvin, L.A. Stevens, J. Manzi, J.W. Kusek, and P. Eggers Prevalence of chronic kidney disease in the United States JAMA 298 2007 2038 2047 (Pubitemid 350074801)
17. S.J. Chadban, E.M. Briganti, P.G. Kerr, D.W. Dunstan, T.A. Welborn, and P.Z. Zimmet Prevalence of kidney damage in Australian adults: The AusDiab kidney study J Am Soc Nephrol 14 Suppl 2 2003 S131 S138
18. F. Simal, J.C. Martin, J. Bellido, D. Arzúa, F.J. Mena, and I. González Prevalencia de la enfermedad renal crónica leve y moderada en población general Nefrologia 24 2004 329 337
19. A.L. De Francisco, and A. Otero Insuficiencia renal oculta: estudio Epirce Nefrologia 25 Suppl 4 2005 66 71
20. A. Otero, P. Gayoso, F. García, A.L. De Francisco on behalf of the EPIRCE study group Epidemiology of chronic renal disease in the Galician population: results of the pilot Spanish EPIRCE study Kidney Int Suppl 99 2005 S16 S19
21. Otero A, Gayoso P, Garcia F, De Francisco ALM. EPIRCE Resultado final. Datos aún no publicados.
22. A.L.M. De Francisco, J.J. De la Cruz, A. Cases, M. de la Figuera, M.I. Egocheaga, and J.I. Górriz Prevalencia e insuficiencia renal en centros de atención primaria de España Estudio EROCAP. Nefrologia. 27 2007 300 312
23. L. Vara-González, E. Martín, T. Ureña, A. Dalfó, I. Becerra, and V. López Prevalencia de enfermedad renal crónica en hipertensos seguidos en los centros de salud de España y grado de control de su presión arterial (estudio DISEHTAE) Aten Primaria 40 2008 241 245
24. A. Meguid El Nahas, and A.K. Bello Chronic kidney disease: the global challenge Lancet 365 2005 331 340
25. A.S. Levey, R. Atkins, J. Coresh, E.P. Cohen, A.J. Collins, and K.U. Eckardt Chronic kidney disease as a global public health-problem approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes Kidney Int 72 2007 247 259
26. A.L. De Francisco, G.F. Fresnedo, R. Palomar, C. Piñera, and M. Arias The renal benefits of a healthy lifestyle Kidney Int Suppl 99 2005 S2 S6
27. G. Remuzzi, A. Benigni, and A. Remuzzi Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes J Clin Invest 116 2006 288 296
28. C.R. Harper, and T.A. Jacobson Managing dyslipidemia in chronic kidney disease J Am Coll Cardiol 51 2008 2375 2384
29. J. Shepherd, J.J. Kastelein, V. Bittner, P. Deedwania, A. Breazna, S. Dobson TNT (Treating to New Targets) Investigators Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study J Am Coll Cardiol 51 2008 1448 1454
30. N.J. Wald, and N.R. Law A strategy to reduce cardiovascular disease by more than 80% BMJ 326 2003 1419
31. V. Fuster, and G. Sanz A polypill for secondary prevention: time to move from intellectual debate to action Nat Clin Pract Cardiovasc Med 4 2007 173
32. V. Fuster, and J. Voûte MDGs chronic diseases are not on the agenda Lancet 366 2005 1578 1582